Continued strong revenue growth and operational efficiency
2021 Second Quarter Highlights:
Positive Adjusted EBITDA1 of $3.6 million
Consolidated net revenue of $18.3 million
54% net revenue growth quarter-over-quarter
52 active retail SKUs with 9 new SKUs introduced in Q2, with presence in all 10 provinces
Completed fourth shipment of medical cannabis to Israel through its Truverra brand
Maintains a strong liquidity position, including a cash balance of $41.9 million pro forma including net proceeds of $21.5 million from the unit offering subsequent to quarter end
News 
Market Data 
Discover 
